Trulieve Cannabis price target lowered to C$19 from C$23 at Alliance Global Partners

Alliance Global Partners lowered the firm’s price target on Trulieve Cannabis (TCNNF) to C$19 from C$23 and keeps a Buy rating on the shares. Entering 2025, sentiment within the cannabis group is low after a lack of progress on federal reform in 2024, says the analyst, who expects stock movement within the industry to be most tied to anticipation of federal cannabis reform coming to fruition. However, “there is uncertainty today,” the analyst tells investors.